Patient Guide: BRAVESST2: First-in-human Phase 1/2 study of CRN09682 in SST2-positive neuroendocrine tumors and SST2-expressing solid tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTCRN09682-BRAVESST2
Status: 🟢 Enrolling Now
Condition: Neuroendocrine tumors, SST2-expressing solid tumors
Phase: PHASE1, PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily